[HTML][HTML] The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial
P O'Donnell, C Dong, V Murthy… - …, 2023 - nature.com
Several attempts have been made to enhance N-methyl-D-aspartate (NMDA) receptor
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …
The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial.
P O'Donnell, C Dong, V Murthy… - …, 2023 - psycnet.apa.org
Several attempts have been made to enhance N-methyl-D-aspartate (NMDA) receptor
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …
The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial
P O'Donnell, C Dong, V Murthy… - … : Official Publication of …, 2023 - europepmc.org
Several attempts have been made to enhance N-methyl-D-aspartate (NMDA) receptor
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …
The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial
P O'Donnell, C Dong, V Murthy, M Asgharnejad, X Du… - 2023 - pubmed.ncbi.nlm.nih.gov
Several attempts have been made to enhance N-methyl-D-aspartate (NMDA) receptor
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …
[HTML][HTML] The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial
P O'Donnell, C Dong, V Murthy… - …, 2023 - ncbi.nlm.nih.gov
Several attempts have been made to enhance N-methyl-D-aspartate (NMDA) receptor
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …
The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial.
P O'Donnell, C Dong, V Murthy… - … : Official Publication of …, 2023 - europepmc.org
Several attempts have been made to enhance N-methyl-D-aspartate (NMDA) receptor
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …
function in schizophrenia, but they have yielded mixed results. Luvadaxistat, a D-amino acid …